reglab/statecodes huggingface dataset:
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 7 - CERTIFICATION OF ADVANCED PRACTICE NURSES › Section 13:37-7.6 - Certification by endorsement

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An advanced practice nurse certified in another state shall be eligible for certification in this State without meeting the examination requirements of 13:37-7.4 if the educational requirements of the state in which he or she is certified are substantially similar to the educational requirements of this State.
(b) An applicant for advanced practice nurse certification who is certified in another state shall submit to the Board:
1. A completed application form, which contains biographical, educational and experiential data concerning the applicant;
2. Verification of certification as an advanced practice nurse in good standing in another state;
3. Proof that the applicant has successfully completed the educational requirements of an advanced practice nurse as set forth in 13:37-7.2. The applicant shall submit to the Board a transcript showing successful completion of an advanced practice nurse program from the school(s) where the applicant completed the educational requirements. An applicant applying for certification through endorsement shall not be required to meet the requirements of 13:37-7.2(b);
4. Proof that the applicant is currently certified by a national certifying agency that is accredited by the American Board of Nursing Specialties and/or the National Commission for Certifying Agencies; and
5. The application fee set forth in 13:37-5.5(e).
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 7 - CERTIFICATION OF ADVANCED PRACTICE NURSES › Section 13:37-7.7 - Biennial certificate renewal; certificate suspension; reinstatement of suspended certificate; inactive status; return from inactive status

Current through Register Vol. 56, No. 14, July 15, 2024
(a) All certificates for advanced practice nurses shall be issued for a two-year certification period that coincides with the advanced practice nurse's registered professional nurse licensure renewal period. An advanced practice nurse who seeks renewal of the certificate shall submit a renewal application, proof that the applicant is currently certified by a national certifying agency that is accredited by the American Board of Nursing Specialties, and/or the National Commission for Certifying Agencies, and the renewal fee set forth in N.J.A.C. 13:37-5.5 prior to the expiration date of the certificate. An advanced practice nurse who is certified prior to June 16, 2008, shall not have to show that he or she is certified by a national certifying agency.
(b) The Board shall send a notice of renewal to each advanced practice nurse, at least 60 days prior to the expiration of his or her certificate. If the notice to renew is not sent at least 60 days prior to the expiration date, no monetary penalties or fines shall apply to the holder for failure to renew.
(c) If an advanced practice nurse does not renew the certificate prior to its expiration date, the advanced practice nurse may renew the certificate within 30 days of its expiration by submitting a renewal application, proof that the applicant is currently certified by a national certifying agency that is accredited by the American Board of Nursing Specialties, and/or the National Commission for Certifying Agencies, a renewal fee, and a late fee, as set forth in N.J.A.C. 13:37-5.5.
(d) A certificate that is not renewed within 30 days of its expiration shall be automatically suspended. An individual who continues to practice with a suspended certificate shall be deemed to be engaged in unlicensed practice.
(e) An advanced practice nurse whose certificate has been automatically suspended for five years or less for nonpayment of a biennial renewal fee pursuant to (c) above may be reinstated by the Board upon completion of the following:
1. Payment of the reinstatement fee and all past delinquent biennial renewal fees pursuant to 13:37-5.5;
2. Completion of the continuing education units required under 13:37-7.8 for each biennial registration period for which the advanced practice nurse was suspended; and
3. Submission of an affidavit of employment listing each job held during the period the certificate was suspended, including the name, address, and telephone number of each employer.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 7 - CERTIFICATION OF ADVANCED PRACTICE NURSES › Section 13:37-7.8 - Continuing education

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Every biennial period, an advanced practice nurse shall complete the continuing education required for the renewal of a registered professional nurse license pursuant to N.J.A.C. 13:37-5.3 and the continuing education requirements of the national certifying agency whose examination the advanced practice nurse successfully passed pursuant to N.J.A.C. 13:37-7.4 or 7.5.
(b) Pursuant to P.L. 2011, c. 145 (N.J.S.A. 45:11-47.1), two credits of the continuing education completed pursuant to (a) above shall be in programs or topics related to end-of-life care.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 7 - CERTIFICATION OF ADVANCED PRACTICE NURSES › Section 13:37-7.9 - Prescriptive practice

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An advanced practice nurse may prescribe or order medications and devices and shall do so in conformity with the provisions of this subchapter, 45:11-45 et seq., and written protocols for the prescription of medications and devices jointly developed by the advanced practice nurse and the collaborating physician in accordance with the standards of 45:11-51 and N.J.A.C. 13:37-6.3.
(b) An advanced practice nurse may prescribe or order treatments, including referrals, and shall do so in conformity with the provisions of this subchapter and 45:11-45 et seq.
(c) An advanced practice nurse who issues prescriptions in any setting other than in a licensed acute care or long-term care facility may issue written prescriptions for medications to patients only on New Jersey Prescription Blanks in accordance with 45:14-55.
(d) An advanced practice nurse shall include the following information on each prescription blank issued:
1. The prescribing advanced practice nurse's full name, designation, that is, APN, address, telephone number, and certification number;
2. The full name, date of birth and address of the patient;
3. The date of issuance;
4. The name, strength, route and quantity of the medication prescribed;
5. The number of refills permitted or time limit for refills, or both;
6. A handwritten, original signature;
7. An explicit indication, by initials placed next to "do not substitute," if a specified brand name drug is to be dispensed;
8. The full name, title, address, telephone number, and license number of the collaborating physician;
9. Words, in addition to numbers, to indicate the drug quantity authorized if the prescription is for a controlled dangerous substance, for example: "ten (10) Percodan" or "five (5) Ritalin 5 mg"; and
10. If the prescription is for a controlled dangerous substance, the advanced practice nurse's DEA number and instructions as to the frequency of use.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 7 - CERTIFICATION OF ADVANCED PRACTICE NURSES › Section 13:37-7.9A - Limitations on prescribing, administering, or dispensing of controlled dangerous substances; special requirements for management of acute and chronic pain

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The following words and terms when used in this section, shall have the following meanings, unless the context clearly indicates otherwise:
"Acute pain" means the pain, whether resulting from disease, accidental or intentional trauma, or other cause, that the practitioner reasonably expects to last only a short period of time. "Acute pain" does not include chronic pain, pain being treated as part of cancer care, hospice or other end of life care, or pain being treated as part of palliative care.
"Chronic pain" means pain that persists or recurs for more than three months.
"Initial prescription" means a prescription issued to a patient who:
1. Has never previously been issued a prescription for the drug or its pharmaceutical equivalent; or
2. Was previously issued a prescription for, or used or was administered, the drug or its pharmaceutical equivalent, and the date on which the current prescription is being issued is more than one year after the date the patient last used or was administered the drug or its equivalent. When determining whether a patient was previously issued a prescription for, or used or was administered, a drug or its pharmaceutical equivalent, the practitioner shall consult with the patient, review prescription monitoring information, and, to the extent it is available to the practitioner, review the patient's medical record.
"Opioid antidote" means any drug, regardless of dosage amount or method of administration, which has been approved by the United States Food and Drug Administration (FDA) for the treatment of an opioid overdose. "Opioid antidote" includes, but is not limited to, naloxone hydrochloride, in any dosage amount, which is administered through nasal spray or any other FDA-approved means or methods.
"Palliative care" means care provided to an individual suffering from an incurable progressive illness that is expected to end in death, which is designed to decrease the severity of pain, suffering, and other distressing symptoms, and the expected outcome of which is to enable the individual to experience an improved quality of life.
"Practitioner" means a certified advanced practice nurse currently authorized to prescribe drugs in the course of professional practice, acting within the scope of his or her certification.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 7 - CERTIFICATION OF ADVANCED PRACTICE NURSES › Section 13:37-7.10 - Requirements for dispensing medications

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An advanced practice nurse may dispense a medication directly to a patient pursuant to a joint protocol. An advanced practice nurse who dispenses medications shall assure that follow-up care is provided and that the effects of the medication are properly evaluated and integrated into the treatment plan of the patient.
(b) An advanced practice nurse who dispenses medications in the office shall maintain those medications in accordance with pharmaceutical standards and manufacturer recommendations concerning storage conditions. An advanced practice nurse shall not maintain in inventory any medications, which are outdated, misbranded, deteriorated, adulterated, recalled, unlabeled, damaged, discontinued or which were previously dispensed to a patient.
(c) When an advanced practice nurse dispenses a medication to a patient, he or she shall record the dispensing in the patient's record.
(d) All medications dispensed, except for those dispensed as pharmaceutical samples shall be recorded in a permanent, contemporaneous dispensing log, which shall contain the following:
1. The full name of the patient;
2. The complete name of each medication dispensed;
3. The strength and quantity of the medication dispensed;
4. Instructions as to the frequency of use;
5. The date of dispensing; and
6. The identity of the dispensing advanced practice nurse, if more than one individual dispenses in the office.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 7 - CERTIFICATION OF ADVANCED PRACTICE NURSES › Section 13:37-7.10A - Dispensing narcotic drugs for maintenance or detoxification treatment

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An advanced practice nurse may dispense narcotic drugs for maintenance or detoxification treatment if the advanced practice nurse has met the training requirements of, and is registered pursuant to, subsection (G) of 21 U.S.C. §
										823.
(b) If an advanced practice nurse is qualified to dispense narcotic drugs for maintenance or detoxification treatment pursuant to (a) above, he or she may dispense such drugs even if his or her collaborating physician has not met the requirements of subsection (G) of 21 U.S.C. §
										823, as long as the joint protocol between the advanced practice nurse and the collaborating physician includes the physician's written approval for the dispensing of such drugs.
(c) An advanced practice nurse may prescribe services for treatment of substance use disorder, pursuant to the joint protocol between the advanced practice nurse and his or her collaborating physician.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 7 - CERTIFICATION OF ADVANCED PRACTICE NURSES › Section 13:37-7.11 - Practice as a registered professional nurse

Current through Register Vol. 56, No. 14, July 15, 2024
Nothing in 45:11-45 et seq. or this subchapter shall be construed to limit, preclude or otherwise interfere with the practice of nursing as defined by 45:11-23 by a person licensed as a registered professional nurse in this State, provided that the licensee does not represent himself or herself as an advanced practice nurse.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8 - NURSING PRACTICE › Section 13:37-8.1 - Standards for joint protocols between advanced practice nurses and collaborating physicians

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The following words and terms, when used in this section, shall have the following meanings, unless the context clearly indicates otherwise.
"Collaboration" means the ongoing process by which an advanced practice nurse and a physician engage in practice, consistent with agreed upon parameters of their respective practices.
"Device" means an article, other than medication, for use in the diagnosis, cure, mitigation, treatment or prevention of disease, injury, pain or deformity or physical or emotional condition or health problem in humans or intended to affect the structure or function of the human body.
"Joint protocol" means an agreement or contract between an advanced practice nurse and a collaborating physician which conforms to the standards established by the Director of the Division of Consumer Affairs pursuant to this rule.
"Medication" means any substance for which a prescription is required which is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease, injury, pain or deformity or physical or emotional condition or health problem in humans or intended to affect the structure or function of the human body.
(b) Advance practice nurses who seek to prescribe or order medications or devices and the collaborating physician(s) with whom they are in collaboration shall develop a joint protocol, which shall be:
1. In writing;
2. Signed by both the advanced practice nurse and the physician, with an acknowledgment that any inappropriate professional behavior or violation of the protocol on the part of either the physician or the advanced practice nurse will be reported to his or her respective licensing board;
3. Maintained on the premises of every office in which the advanced practice nurse practices;
4. Updated on an ongoing basis to reflect changes in the practice, office personnel, skills of the advanced practice nurse, frequency of record review, and reference materials containing practice guidelines or accepted standards of practice; and
5. Reviewed at least on an annual basis.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8 - NURSING PRACTICE › Section 13:37-8.2 - Identification tags

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Each licensee shall wear an identification tag when engaging in the practice for which the individual is licensed. The identification tag shall be clearly visible at all times, and such tag shall bear the first name or initial, the full surname and the term reflecting the individual's level of licensure, for example, Registered Nurse or R.N. The letters on the tag shall be of equal size in type, not smaller than one-quarter inch. The size of the identification tag shall be equal to or greater than that of any other identification worn by the licensee.
(b) Where a general hospital requires a facility staff member who is a licensee to wear an identifying badge pursuant to P.L. 1997, c. 76 (N.J.S.A. 26:2H-12.8a ), that staff member need wear only one identification badge, as long as the badge meets requirements of both P.L. 1997, c. 76 (N.J.S.A. 26:2H-12.8a ) and (a) above.
(c) In order to protect his or her personal safety or to prevent the substantial invasion of his or her privacy, or to prevent the identification tag from causing physical harm to the patient, a licensee may request an exemption from the requirements of (a) above. Such requests for an exemption shall be made by the licensee in writing to the Board and shall set forth the reasons why wearing the tag would endanger the licensee's personal safety, substantially invade the licensee's privacy, or physically harm a patient.
(d) The exemption set forth in (c) above shall not apply to those facility staff members in a general hospital, where such general hospital requires a facility staff member to wear an identifying badge pursuant to P.L. 1997, c. 76 (26:2H-12.8a ).
(e) The exemption set forth in (c) above shall not apply to a nurse providing home-based services for a registered health care service firm who is required to wear an identification tag pursuant to N.J.S.A. 34:8-79.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8 - NURSING PRACTICE › Section 13:37-8.3 - Sexual misconduct

Current through Register Vol. 56, No. 14, July 15, 2024
(a) This section shall apply to all advanced practice nurses, registered professional nurses, and licensed practical nurses licensed or certified by the Board.
(b) As used in this section, the following terms have the following meanings unless the context indicates otherwise:
"Board" means the New Jersey Board of Nursing.
"Licensee" means any person licensed or certified by the Board.
"Patient" means any person who is the recipient of nursing services rendered by a licensee pursuant to N.J.S.A. 45:11-23 et seq.
"Patient relationship" means an association between a licensee and patient wherein the licensee owes a continuing duty to the patient to be available to render nursing services consistent with the licensee's education, training, and experience.
"Sexual contact" means the knowing touching of a person's body directly or through clothing, where the circumstances surrounding the touching would be construed by a reasonable person to be motivated by the licensee's own prurient interest or for sexual arousal or gratification. "Sexual contact" includes the imposition of a part of the licensee's body upon a part of the patient's body, sexual penetration, or the insertion or imposition of any object or any part of a licensee or patient's body into or near the genital, anal, or other opening of the other person's body.
"Sexual harassment" means solicitation of any sexual act, physical advances, or verbal or non-verbal conduct that is sexual in nature, and which occurs in connection with a licensee's activities or role as a provider of nursing services, and that either: is unwelcome, offensive to a reasonable person, or creates a hostile environment, and the licensee knows, should know or is told this; or is sufficiently severe or intense to be abusive to a reasonable person in that context. "Sexual harassment" may consist of a single extreme or severe act or of multiple acts and may include conduct of a licensee with an individual whether or not such individual is in a subordinate position to the licensee.
"Spouse" means either the husband, wife or fiancee of the licensee or an individual in a long-term committed relationship with the licensee.
(c) A licensee shall not engage in sexual contact with a patient with whom he or she has a patient relationship. The patient relationship is considered ongoing for purposes of this section unless:
1. For an advanced practice nurse, registered professional nurse or licensed practical nurse, who is not engaged in psychiatric nursing, the last nursing service was rendered more than three months prior;
2. For an advanced practice nurse who practices psychiatric nursing, the last nursing service was rendered more than two years prior; or
3. For a registered professional nurse or a licensed practical nurse who practices psychiatric nursing, the last nursing service was rendered more than one year prior.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8 - NURSING PRACTICE › Section 13:37-8.4 - Nurse Licensure Compact regulations

Current through Register Vol. 56, No. 14, July 15, 2024
The Interstate Commission of Nurse Licensure Compact Administrators Final Rules (2019), available from National Council of State Boards of Nursing, 111 East Wacker Drive, Suite 2900, Chicago, IL 60601-4277 and at
http://www.ncsbn.org/nlcrules.htm
, are incorporated herein by reference, as amended and supplemented.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8A - TELEMEDICINE › Section 13:37-8A.1 - Purpose and scope

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The purpose of this subchapter is to implement the provisions of P.L. 2017, c. 117 (N.J.S.A. 45:1-61et seq.), which authorizes healthcare providers to engage in telemedicine and telehealth.
(b) This subchapter shall apply to all persons who are licensed by the Board as nurses.
(c) Pursuant to N.J.S.A. 45:1-62, a nurse must hold a license issued by the Board if he or she:
1. Is located in New Jersey and provides health care services to any patient located in or out of New Jersey by means of telemedicine or telehealth; or
2. Is located outside of New Jersey and provides health care services to any patient located in New Jersey by means of telemedicine or telehealth.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8A - TELEMEDICINE › Section 13:37-8A.2 - Definitions

Current through Register Vol. 56, No. 14, July 15, 2024
The following words and terms, when used in this subchapter, shall have the following meanings, unless the context clearly indicates otherwise.
"Asynchronous store-and-forward" means the acquisition and transmission of images, diagnostics, data, and medical information either to or from an originating site or to or from the licensee at a distant site, which allows for the patient to be evaluated without being physically present.
"Board" means the Board of Nursing.
"Cross-coverage" means a licensee who engages in a remote medical evaluation of a patient, without in-person contact, at the request of another licensee who has established a proper licensee-patient relationship with the patient.
"Distant site" means a site at which a licensee is located while providing health care services by means of telemedicine or telehealth.
"Licensee" means an individual licensed by the Board as a registered professional nurse or a licensed practical nurse or certified as an advanced practice nurse.
"On-call" means a licensee is available, where necessary, to physically attend to the urgent and follow-up needs of a patient for whom the licensee has temporarily assumed responsibility, as designated by the patient's primary care licensee or other health care provider of record.
"Originating site" means a site at which a patient is located at the time that health care services are provided to the patient by means of telemedicine or telehealth.
"Proper licensee-patient relationship" means an association between a licensee and patient wherein the licensee owes a duty to the patient to be available to render professional services consistent with his or her training and experience, which is established pursuant to the requirements of N.J.A.C. 13:37-8A.4.
"Telehealth" means the use of information and communications technologies, including telephones, remote patient monitoring devices, or other electronic means, to support clinical health care, provider consultation, patient and professional health-related education, public health, health administration, and other services in accordance with the provisions of P.L. 2017, c. 117 (N.J.S.A. 45:1-61et seq.).
"Telemedicine" means the delivery of a health care service, including supportive mental health services, using electronic communications, information technology, or other electronic or technological means to bridge the gap between a licensee who is located at a distant site and a patient who is located at an originating site, either with or without the assistance of an intervening licensee, and in accordance with the provisions of P.L. 2017, c. 117 (N.J.S.A. 45:1-61et seq.). "Telemedicine" does not include the use, in isolation, of audio-only telephone conversation, electronic mail, instant messaging, phone text, or facsimile transmission.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8A - TELEMEDICINE › Section 13:37-8A.3 - Standard of care

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Prior to providing services through telemedicine or telehealth, a licensee shall determine whether providing those services through telemedicine or telehealth would be consistent with the standard of care applicable for those services when provided in-person.
(b) If a licensee determines, either before or during the provision of health care services, that services cannot be provided through telemedicine or telehealth in a manner that is consistent with in-person standards of care, the licensee shall not provide services through telemedicine or telehealth.
(c) A licensee who determines that services cannot be provided through telemedicine or telehealth pursuant to (b) above shall advise the patient to obtain services in-person.
(d) A licensee who provides a diagnosis, treatment, or consultation recommendation, including discussions regarding the risk and benefits of a patient's treatment options, through telemedicine or telehealth shall be held to the same standard of care or practice standards as are applicable to in-person settings.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8A - TELEMEDICINE › Section 13:37-8A.4 - Licensee-patient relationship

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Prior to providing services through telemedicine or telehealth, a licensee shall establish a licensee-patient relationship by:
1. Identifying the patient with, at a minimum, the patient's name, date of birth, phone number, and address. A licensee may also use a patient's assigned identification number, Social Security number, photo, health insurance policy number, or other identifier associated directly with the patient; and
2. Disclosing and validating the licensee's identity, license, title, and, if applicable, specialty and board certifications.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8A - TELEMEDICINE › Section 13:37-8A.5 - Provision of health care services through telemedicine or telehealth

Current through Register Vol. 56, No. 14, July 15, 2024
(a) As long as a licensee has satisfied the requirements of N.J.A.C. 13:37-8A.4, a licensee may provide health care services to a patient through the use of telemedicine and may engage in telehealth to support and facilitate the provision of health care services to patients.
(b) Prior to providing services through telemedicine or telehealth, a licensee shall determine the patient's originating site and record this information in the patient's record.
(c) A licensee providing healthcare services through telemedicine shall use interactive, real-time, two-way communication technologies, which shall include, except as provided in (e) below, a video component that allows a licensee to see a patient and the patient to see the licensee during the provision of health care services.
(d) A licensee providing services through telemedicine or telehealth may use asynchronous store-and-forward technology to allow for the electronic transmission of:
1. Images;
2. Diagnostics;
3. Data; and
4. Medical information.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8A - TELEMEDICINE › Section 13:37-8A.6 - Prescriptions

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An advanced practice nurse providing services through telemedicine or telehealth may issue a prescription to a patient, as long as the issuance of such a prescription is consistent with the standard of care or practice standards applicable to the in-person setting.
(b) An advanced practice nurse shall not issue a prescription based solely on responses provided in an online questionnaire, unless the advanced practice nurse has established a proper licensee-patient relationship pursuant to N.J.A.C. 13:37-8A.4.
(c) Notwithstanding (a) above, and except as provided in (d) below, an advanced practice nurse shall not issue a prescription for a Schedule II controlled dangerous substance unless the advanced practice nurse has had an initial in-person examination of the patient and a subsequent in-person visit with the patient at least every three months for the duration of the time the patient is prescribed the Schedule II controlled dangerous substance.
(d) The prohibition of (c) above shall not apply when an advanced practice nurse prescribes a stimulant for a patient under the age of 18 years, as long as the advanced practice nurse is using interactive, real-time, two-way audio and video technologies and the advanced practice nurse has obtained written consent for a waiver of in-person examination requirements from the patient's parent or guardian.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8A - TELEMEDICINE › Section 13:37-8A.7 - Records

Current through Register Vol. 56, No. 14, July 15, 2024
A licensee who provides services through telemedicine or telehealth shall maintain a record of the care provided to a patient. Such records shall comply with applicable State and Federal statutes, rules, and regulations for recordkeeping, confidentiality, and disclosure of a patient's medical record.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8A - TELEMEDICINE › Section 13:37-8A.8 - Prevention of fraud and abuse

Current through Register Vol. 56, No. 14, July 15, 2024
(a) In order to establish that a licensee has made a good faith effort to prevent fraud and abuse when providing services through telemedicine or telehealth, a licensee must establish written protocols that address:
1. Authentication and authorization of users;
2. Authentication of the patient during the initial intake pursuant to N.J.A.C. 13:37-8A.4(a)1;
3. Authentication of the origin of information;
4. The prevention of unauthorized access to the system or information;
5. System security, including the integrity of information that is collected, program integrity, and system integrity;
6. Maintenance of documentation about system and information usage;
7. Information storage, maintenance, and transmission; and
8. Synchronization and verification of patient profile data.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 8A - TELEMEDICINE › Section 13:37-8A.9 - Privacy and notice to patients

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Licensees who communicate with patients by electronic communications other than telephone or facsimile shall establish written privacy practices that are consistent with Federal standards under 45 CFR 160 and 164, as amended and supplemented, which are incorporated herein by reference, relating to privacy of individually identifiable health information.
(b) Written privacy practices required by (a) above shall include privacy and security measures that assure confidentiality and integrity of patient-identifiable information. Transmissions, including patient email, prescriptions, and laboratory results must be password protected, encrypted electronic prescriptions, or protected through substantially equivalent authentication techniques.
(c) A licensee who becomes aware of a breach in confidentiality of patient information, as defined in 45 CFR 164.402, shall comply with the reporting requirements of 45 CFR Part 164.
(d) Licensees, or their authorized representatives, shall provide a patient, prior to evaluation or treatment, with copies of written privacy practices and shall obtain the patient's written acknowledgement of receipt of the notice.
(e) Licensees who provide services through telemedicine or telehealth, or their authorized representatives, shall, prior to providing services, give patients notice regarding telemedicine and telehealth, including the risks and benefits of being treated through telemedicine or telehealth and how to receive follow-up care or assistance in the event of an adverse reaction to the treatment or in the event of an inability to communicate as a result of a technological or equipment failure. A licensee shall obtain a signed and dated statement indicating that the patient received this notice.
(f) When telemedicine or telehealth is unable to provide all pertinent clinical information that a licensee exercising ordinary skill and care would deem reasonably necessary to provide care to a patient, the licensee shall inform the patient of this prior to the conclusion of the provision of care through telemedicine or telehealth and shall advise the patient regarding the need for the patient to obtain an additional in-person evaluation reasonably able to meet the patient's needs.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 9 - FORENSIC NURSE-CERTIFIED SEXUAL ASSAULT PROGRAM › Section 13:37-9.1 - Purpose and scope

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The purpose of this subchapter is to implement the provisions of P.L. 2001, c. 81, which establishes a Statewide Sexual Assault Nurse Examiner Program and authorized the certification of sexual assault nurse examiners by the Board and the Attorney General.
(b) This subchapter sets forth standards for the education and certification of forensic nurses certified in sexual assault.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 9 - FORENSIC NURSE-CERTIFIED SEXUAL ASSAULT PROGRAM › Section 13:37-9.2 - Definitions

Current through Register Vol. 56, No. 14, July 15, 2024
The following words and terms, when used in this subchapter, shall have the following meanings, unless the context clearly indicates otherwise:
"Board" means the State Board of Nursing.
"Certification" means the formal process by which education is received and the clinical competency of the FN--CSA is demonstrated.
"Forensic nurse-certified sexual assault (FN-CSA)" means a registered professional nurse licensed in New Jersey. and specially trained to provide comprehensive care to sexual assault victims, who demonstrates competency in conducting a sexual assault forensic examination and who has successfully completed a course of education as set forth in this subchapter.
"Full-time" means that a person has worked at least 800 hours in one year.
"Medical screening examination" means an examination and evaluation within the capability of a hospital's emergency department, including ancillary services routinely available to the emergency department, performed by qualified personnel pursuant to requirements in N.J.A.C. 8:43G-12, which are necessary to determine whether or not an emergency medical condition exists.
"Sexual assault forensic examination" means an assessment conducted by a physician or a registered professional nurse, consisting of a history and physical examination, medical or nursing diagnosis and intervention, including the collection of evidence.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 9 - FORENSIC NURSE-CERTIFIED SEXUAL ASSAULT PROGRAM › Section 13:37-9.3 - Application for certification

Current through Register Vol. 56, No. 14, July 15, 2024
(a) To be eligible for certification as a FN-CSA, an applicant must:
1. Hold a current license as a registered professional nurse from the Board or a registered professional nurse multistate license from a state which is part of the Nurse Licensure Compact;
2. Have worked full-time for at least two years as a registered professional nurse;
3. Have successfully completed a FN-CSA education course approved by the Board and the Director of the Division of Criminal Justice, pursuant to 13:37-9.5; and
4. Have successfully completed the FN-CSA clinical requirement pursuant to 13:37-9.6 and passed a clinical examination given by an approved clinical examination facility pursuant to 13:37-9.7(d).
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 9 - FORENSIC NURSE-CERTIFIED SEXUAL ASSAULT PROGRAM › Section 13:37-9.5 - FN-CSA education programs

Current through Register Vol. 56, No. 14, July 15, 2024
(a) An individual, agency or institution seeking approval for a course in clinical forensics for the purpose of providing education for forensic nurses-certified sexual assault shall submit to the Board an application which shall include:
1. The name and address of the individual, agency or institution seeking approval;
2. Proof that the program has been accredited by the American Nurses Credentialing Center's Commission on Accreditation;
3. An outline of the course curriculum specifying the hours allotted to each topic;
4. An affidavit which indicates that the curriculum is included in the FN-CSA education course;
5. An affidavit that program instructors meet the requirements of (d) below;
6. The names and credentials of all instructors for the program; and
7. The name and credentials of the program administrator.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 9 - FORENSIC NURSE-CERTIFIED SEXUAL ASSAULT PROGRAM › Section 13:37-9.6 - Clinical education

Current through Register Vol. 56, No. 14, July 15, 2024
(a) Applicants for certification as a FN-CSA shall complete classroom education, pursuant to 13:37-9.5, before beginning their clinical education.
(b) An applicant shall complete a clinical program that meets guidelines on clinical education found in the 2015 edition of the International Association of Forensic Nurses' Sexual Assault Nurse Examiner Education Guidelines, incorporated herein by reference, as amended and supplemented, published by the International Association of Forensic Nurses, 6755 Business Parkway, Suite 303, Elkridge, MD, 21075.
(c) Documentation of the completed clinical education shall be dated and signed by the supervising advanced practice nurse, physician, Forensic Nurse Coordinator, or FN-CSA who holds a master's degree in nursing and has been working as an FN-CSA for at least two years.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 9 - FORENSIC NURSE-CERTIFIED SEXUAL ASSAULT PROGRAM › Section 13:37-9.7 - Clinical education facilities

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A Board accredited school of nursing may apply to the Board for approval as a clinical education facility. An applicant for approval shall submit to the Board:
1. Documents which show that the clinical education facility is equipped with a colposcope and all other equipment needed for a comprehensive sexual assault forensic examination;
2. Evidence that the clinical education facility has a person who will act as a surrogate sexual assault victim;
3. An outline of what the person(s) acting as a surrogate sexual assault victim will say during a sexual assault examination;
4. Evidence that the clinical education facility can provide the opportunity for individuals to complete the five sexual assault examinations required by 13:37-9.6(b); and
5. After July 13, 2005, evidence that the training facility has an instructor who is a FN-CSA.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 9 - FORENSIC NURSE-CERTIFIED SEXUAL ASSAULT PROGRAM › Section 13:37-9.8 - Renewal of certification

Current through Register Vol. 56, No. 14, July 15, 2024
(a) All FN-CSA certificates shall be issued for a two-year certification period, which coincides with the FN-CSA's registered professional nurse licensure renewal period. An FN-CSA who seeks renewal of the certificate shall submit a renewal application and the biennial renewal fee set forth in 13:37-5.5, prior to the expiration date of the certificate.
(b) The Board shall send a notice of renewal to each FN-CSA at least 60 days prior to the expiration of the certificate. If the notice to renew is not sent at least 60 days prior to the expiration date, no monetary penalties or fines shall apply to the holder for any uncertified practice during the period following the certification expiration, not to exceed the number of days short of 60 before the renewals were issued.
(c) If an FN-CSA does not renew the certificate prior to its expiration date, the FN-CSA may renew the certificate within 30 days of its expiration by submitting a renewal application and a renewal fee as set forth in 13:37-5.5(e). If the FN-CSA has not paid a reinstatement fee for renewal of licensure as a registered professional nurse within the same biennial period, the FN-CSA shall pay, in addition to the renewal fee, the reinstatement fee from 13:37-5.5(e).
(d) A certificate that is not renewed within 30 days of its expiration shall be administratively suspended. An individual who continues to practice with an administratively suspended certificate shall be deemed to be engaged in unlicensed practice.
(e) An FN-CSA whose certificate has been administratively suspended for five years or less for nonpayment of a biennial renewal fee pursuant to (c) above may be reinstated by the Board upon completion of the following:
1. Payment of all past delinquent biennial renewal fees pursuant to 13:37-5.5(e);
2. Submission of an affidavit of employment listing each job held during the period the certificate was suspended, including the name, address and telephone number of each employer; and
3. If the FN-CSA has not paid a reinstatement fee for licensure as a registered professional nurse within the same biennial period, the FN-CSA shall pay, in addition to the renewal fees, the reinstatement fee from 13:37-5.5(e).
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 9 - FORENSIC NURSE-CERTIFIED SEXUAL ASSAULT PROGRAM › Section 13:37-9.9 - Revocation or suspension of certification

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The Board and the Director of the Division of Criminal Justice may revoke or suspend a certification, after affording an opportunity to be heard, if they find that a FN-CSA has:
1. Falsified documentation;
2. Violated patient confidentiality;
3. Been convicted of a crime;
4. Been convicted of an offense involving perjury, dishonesty, fraud or misrepresentation, or sex offense; or
5. Violated the provisions of 45:1-21.
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 9 - FORENSIC NURSE-CERTIFIED SEXUAL ASSAULT PROGRAM › Section 13:37-9.10 - Endorsement

Current through Register Vol. 56, No. 14, July 15, 2024
(a) A registered professional nurse, licensed in New Jersey, who is working as a FN-CSA in another state may apply for certification as a FN-CSA in New Jersey if the applicant is certified by another state as a FN-CSA, or its equivalent, and the applicant:
1. Has completed a course and clinical education substantially similar to the requirements of N.J.A.C. 13:37-9.5 and 9.6; and
2. Passes a clinical competency examination given by a clinical examination facility pursuant to 13:37-9.7(d).
New Jersey Administrative Code › Title 13 - LAW AND PUBLIC SAFETY › Chapter 37 - NEW JERSEY BOARD OF NURSING › Subchapter 14 - HOMEMAKER-HOME HEALTH AIDES › Section 13:37-14.1 - Purpose and scope

Current through Register Vol. 56, No. 14, July 15, 2024
(a) The rules in this subchapter are designed to protect the health and safety of the public through certification of homemaker-home health aides (CHHAs), pursuant to N.J.S.A. 45:11-24.d(20).
(b) This subchapter prescribes standards and curricula for CHHA education and training programs that a CHHA, as defined in this subchapter, is required to complete in order to work in this State. This subchapter also establishes standards and requirements for CHHA certification and for the renewal, suspension, or revocation of that certification.